Portfolio company
Avalyn Pharma
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
The company develops inhaled medicines to treat patients with rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Gossamer Bio
This biopharmaceutical company develops inhaled therapies for patients suffering from pulmonary arterial hypertension and interstitial lung disease.
Savara
This biopharmaceutical company develops inhaled therapies for patients with rare respiratory diseases, such as autoimmune pulmonary alveolar proteinosis.
Respira
This biopharmaceutical company develops inhaled drug-device therapies for patients with cardiopulmonary diseases such as pulmonary hypertension and interstitial lung disease.
AirNexis Therapeutics
This company develops inhaled small molecule medicines to treat chronic obstructive pulmonary disease for patients with respiratory conditions.
Breath Therapeutics
This biopharmaceutical company develops inhaled drug-aerosol therapies for patients with bronchiolitis obliterans syndrome and other severe respiratory diseases.
aTyr Pharma
The company develops protein-based immunomodulatory medicines for patients suffering from inflammatory lung diseases, such as pulmonary sarcoidosis, and various types of cancer.
Promedior
This biotechnology company develops drug therapies to treat rare fibrotic diseases for patients with conditions such as idiopathic pulmonary fibrosis and myelofibrosis.
AQUILON PHARMACEUTICALS
The company develops inhaled medicines and nasal sprays for patients with asthma, chronic obstructive pulmonary disease and other respiratory conditions.
